Evidence for the absorption of heparin by rat stomach

Biomedicine and Pharmacotherapy

Volumn 61, Issue 1, 2007, Pages 68-74

  Hiebert, Linda M ^a   Wice, Sandra M ^a   Abdelhameed, Taher ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Absorption; Endothelium; Heparin; Oral; Stomach

Indexed keywords

HEPARIN; TOLONIUM CHLORIDE;

AGAR GEL ELECTROPHORESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DENSITOMETRY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DUODENUM; ENDOTHELIUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH ABSORPTION; STOMACH TUBE; WISTAR RAT;

ANIMALS; DUODENUM; ENDOTHELIUM, VASCULAR; HEPARIN; INTESTINAL ABSORPTION; MALE; RATS; RATS, WISTAR; STOMACH;

EID: 33846570425     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2006.08.006     Document Type: Article

References (35)

1. Kim S.K., Vaishali B., Lee E., Lee S., Lee Y.K., Kumar T.S., et al. Oral delivery of chemical conjugates of heparin and deoxycholic acid in aqueous formulation. Thromb Res 117 (2006) 419-427
2. Jaques L.B., Hiebert L.M., and Wice S.M. Evidence from endothelium of gastric absorption of heparin and of dextran sulfates 8000. J Lab Clin Med 117 2 (1991) 122-130
3. Hiebert L.M., Wice S.M., and Ping T. Tissue distribution of the low molecular weight heparin, tinzaparin, following administration to rats by the oral route. Biomed Pharmacother 58 (2004) 372-380
4. Hiebert L.M., Wice S.M., Ping T., Herr D., and Laux V. Antithrombotic efficacy in a rat model of the low molecular weight heparin, reviparin sodium, administered by the oral route. Thromb Haemost 85 (2001) 114-118
5. Hiebert L.M., Wice S.M., and Ping T. Increased plasma anti-Xa activity and recovery of heparin from urine suggest absorption of orally administered unfractionated heparin in human subjects. J Lab Clin Med 145 (2005) 151-155
6. Hiebert L.M., Wice S.M., and Jaques L.B. Antithrombotic activity of oral unfractionated heparin. J Cardiovasc Pharmacol 28 (1996) 26-29
7. Hiebert L.M. Evidence that orally administered heparins are absorbed. In: Vossoughi J., Fareed J., Mousa S.A., and Karanian J.W. (Eds). Thrombosis research and treatment. Bench to bedside (2004), Medical and Engineering Publishers, Washington DC 553-563
8. Berkowitz S.D., Marder V.J., Kosutic G., and Baughman R.A. Oral heparin administration with a novel drug delivery agent (SNAC) in healthy volunteers and patients undergoing elective total hip arthroplasty. J Thromb Haemost 1 (2003) 1914-1919
9. 14C-labeled porcine intestinal mucosal heparin following administration to rats by the oral route. Can J Physiol Pharm 78 (2000) 307-320
10. Hiebert L.M., and Jaques L.B. The observation of heparin on endothelium after injection. Thromb Res 8 (1976) 195-204
11. Jaques L.B., Wice S.M., and Hiebert L.M. Determination of absolute amounts of heparin and of dextran sulfate in plasma in microgram quantities. J Lab Clin Med 115 4 (1990) 422-432
12. Jaques L.B. Determination of heparin and related sulfated mucopolysaccharides. Methods Biochem Anal 24 (1977) 203-312
13. Engelberg H. Actions of heparin in the atherosclerotic process. Pharmacol Rev 48 (1996) 327-352
14. Engelberg H. Actions of heparin that may affect the malignant process. Cancer 85 2 (1999) 257-272
15. Levine M.N., Lee A.Y., and Kakkar A.K. From Trossseau to targeted therapy: new insights and innovations in thrombosis and cancer. J Thromb Haemost 1 (2003) 1456-1463
16. Gorski A., Wasik M., Nowaczyk M., and Korczak-Kowalska G. Immunomodulating activity of heparin. FASEB J 5 (1991) 2287-2291
17. Bagasra O., and Lischner H.W. Activity of dextran sulfate and other polyanionic polysaccharides against human immunodeficiency virus. J Infect Dis 158 (1988) 1084-1087
18. Folkman J., Weisz P.B., Joullie M.M., Li W.W., and Ewing W.R. Control of angiogenesis with synthetic heparin substitutes. Science 243 (1989) 1490-1493
19. Mandal A.K., Lyden T., and Saklayen M.G. Heparin lowers blood pressure: Biological and clinical perspectives. Kidney Int 47 (1995) 1017-1022
20. Berg D., Berg L.H., Couvaras J., and Harrison H. Chronic fatigue syndrome and/or fibromyalgia as a variation of antiphospholipid antibody syndrome: an explanatory model and approach to laboratory diagnosis. Blood Coagul Fibrinolysis 10 (1999) 435-438
21. Prajapati D.N., Newcomer J.R., Emmons J., Abu-Hajir M., and Binion D.G. Successful treatment of an acute flare of steroid-resistant Crohn's colitis during pregnancy with unfractionated heparin. Inflamm Bowel Dis 8 (2002) 192-195
22. Ang Y.S., Mahmud N., White B., Byrne M., Kelly A., Lawler M., et al. Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease. Aliment Pharmacol Ther 14 (2000) 1015-1022
23. Hiebert L.M. Oral heparins. Clin Lab 48 (2002) 111-116
24. Gorski A., and Lagodzinski Z. Oral heparin prolongs survival of skin allografts. Arch Immunol Ther Exp 39 (1991) 557-562
25. Engelberg H. Orally ingested heparin is absorbed in humans. Clin Appl Thromb Hemost 1 4 (1995) 283-285
26. Bucsi L., and Poor G. Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis. Osteoarthritis Cartilage 6 (1998) 31-36
27. 14C] sucrose octasulfate following oral administration to rats. Pharm Res 19 (2002) 838-844
28. Hiebert L.M., Wice S.M., McDuffie N.M., and Jaques L.B. The heparin target organ - the endothelium. Studies in a rat model. Q J Med 86 (1993) 341-348
29. Mahadoo J., and Wright C.J. Intrapulmonary heparin as a prospective anticoagulant regimen. In: Fareed J.W., Messmore H.L., Fenton J.W., and Brinkhous K.M. (Eds). Perspectives in hemostasis (1981), Permagon Press 233-240
30. Bick R.L., and Ross E.S. Clinical use of intrapulmonary heparin. Semin Thromb Hemost 11 (1985) 213-217
31. de Moerloose P., Gavillet O., Salomon P., and Reber G. Heparin-related activity in peripheral venous blood after percutaneous application of various glycosaminoglycan creams. Blood Coagul Fibrinol 3 (1992) 827-828
32. Sue T.K., Jaques L.B., and Yuen E. Effects of acidity, cations and alcoholic fractionation on absorption of heparin from gastrointestinal tract. Can J Physiol Pharm 54 (1976) 613-617
33. Brayden D., Creed E., O'Connell A., Leipold H., Agarwal R., and Leone-Bay A. Heparin absorption across the intestine: effects of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate in rat in situ intestinal instillations and in Caco-2 monolayers. Pharm Res 14 (1997) 1772-1779
34. Brown H.R., and Hardisty J.F. Oral cavity, esophagus, and stomach. In: Boorman G.A., Eustis S.L., Elwell M.R., Montgomery C.A., and Mackenzie W.F. (Eds). Pathology of the Fischer rat: reference and atlas (1990), Academic Press, San Diego 9-29
35. Ichikawa T., Ishihara K., Kusakabe T., Hiruma H., Kawakami T., and Hotta K. CGRP modulates mucin synthesis in surface mucus cells of rat gastric oxyntic mucosa. Am J Physiol Gastrointest Liver Physiol 279 (2000) G82-G89